Search

everythinglearnresearchcommunity

for

Search:↓

The study developed a 3D model that closely imitates remaining ovarian cancer after treatment and identified a potential drug targeting resistant cancer cells.

The new nanoparticles could improve melanoma treatment by working better than current options.

The drug BAY 1158061 is safe, well-tolerated, and shows potential for treating diseases related to prolactin.

The treatment combining docetaxel, cisplatin, and 5-FU is feasible and effective for advanced head and neck cancer.

2007 research improved understanding of prostate cancer risk, diagnosis, and treatment, but also showed the need for personalized treatment and further study on certain therapies' risks.

Blocking DHT production more strongly may help control advanced prostate cancer and improve quality of life.

The drug IPI-926 is safe at 160 mg daily and may help treat certain tumors, especially basal cell carcinoma.

Enhancing immune response can improve cancer treatment effectiveness.

The treatment showed high response rates and was well-tolerated, potentially extending patient survival.

The protein ER71/ETV2 helps regrow hair after chemotherapy by improving the growth of new blood vessels.

The document concludes that DAB389-IL2 is promising for treating refractory cutaneous T-cell lymphoma, but more research is needed on its effectiveness and side effect management.

Multiphoton microscopy can effectively assess breast cancer treatment responses without labels.

Long-term treatment with palbociclib plus letrozole maintains quality of life in certain breast cancer patients.

GnRH agonist effectively diagnoses and treats postmenopausal hyperandrogenism from ovarian sources.

The document concludes that systemic therapy is becoming more important in treating head and neck cancer, with new treatments showing promise.

Tyrosine kinase inhibitors for endocrine tumors often cause skin issues, requiring early management and treatment adjustments.

Radiation therapy in breast cancer patients changes gene expression related to DNA damage, fibroblast growth, and hair follicle development, which could help improve treatment for radiation-induced fibrosis.

Pulsed electric field treatment may help shrink untreated liver tumors.

Pemigatinib may be effective for treating ZMYM2::FGFR1 fusion-positive leukemia.

Erlotinib can cause persistent excessive hair growth.

Panitumumab treatment can cause unusual hair growth in some colorectal cancer patients.

The document explains how certain drugs block hormones to treat cancers like breast and prostate cancer.

Chemotherapy adds to, but doesn't enhance, the effects of immunotherapy in lung cancer treatment.

Goserelin injections can effectively manage hyperandrogenism symptoms in postmenopausal women who can't have surgery.

Early advanced therapies are crucial for better survival in aggressive insulinoma cases.

ALRN-6924 may prevent hair loss caused by chemotherapy.

Targeted anticancer therapies often cause skin issues, affecting treatment adherence and quality of life.

Tebentafusp-tebn improves survival rates in uveal melanoma patients but has common side effects like rash and fatigue.

Combining letrozole and quercetin in spanlastics may improve breast cancer treatment.